Avient (AVNT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
Annual Meeting scheduled for May 14, 2026, will be held virtually to maximize participation and reduce costs and environmental impact.
Strategic focus shifted to organic growth and innovation, with M&A as a complement, resulting in margin expansion and debt reduction in 2025.
2025 saw flat sales but improved adjusted EBITDA margin, higher adjusted EPS, and $150 million in debt reduction.
Continued investment in talent, digital initiatives, and a culture of safety and ethics.
2026 strategy emphasizes innovation, operational execution, and financial discipline for continued growth.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of eleven director nominees, (2) advisory approval of executive compensation, and (3) ratification of Ernst & Young LLP as independent auditor for 2026.
Board recommends voting FOR all proposals.
Shareholders may submit additional proposals or director nominations for future meetings, following specified procedures.
Board of directors and corporate governance
Ten of eleven director nominees are independent; board committees include Audit, Compensation and Talent, Governance and Corporate Responsibility, and Innovation and Sustainability.
Board recombined Chairman and CEO roles in 2025 for unified leadership, with a Lead Director providing independent oversight.
Annual board and peer evaluations, majority voting policy, and robust stock ownership guidelines for directors and executives.
Board diversity at 27% gender diverse; ongoing focus on broad representation and board refreshment.
Latest events from Avient
- Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.AVNT
Proxy filing27 Mar 2026 - Record margin and EPS growth in 2025; 2026 guidance targets further gains amid uncertainty.AVNT
Q4 202512 Feb 2026 - Q2 2024 delivered 21% EPS growth, margin gains, and higher full-year guidance.AVNT
Q2 20242 Feb 2026 - Q3 sales up 8%, adjusted EPS up 14%, and full-year guidance raised amid broad-based growth.AVNT
Q3 202417 Jan 2026 - Targets 20%+ EBITDA margin and double-digit EPS growth through organic expansion in high-growth markets.AVNT
Investor Day 202411 Jan 2026 - 2024 delivered strong growth and margin gains, with double-digit adjusted EPS growth.AVNT
Q4 202414 Dec 2025 - 2025 proxy covers director elections, executive pay, auditor ratification, and ESG progress.AVNT
Proxy Filing1 Dec 2025 - Key votes include board elections, executive pay, and auditor ratification at the 2025 meeting.AVNT
Proxy Filing1 Dec 2025 - 2% organic sales growth, 4% adjusted EPS growth (ex-FX), and $20.2M net loss from ERP impairment.AVNT
Q1 202519 Nov 2025